Shire US Inc. (United States)

Shire Pharmaceuticals, now part of Takeda, specialized in rare diseases, neuroscience, and gastrointestinal conditions. Key products included ADHD treatments Vyvanse and Adderall, hereditary angioedema treatments, and lysosomal storage disorder therapies. Takeda continues Shire’s rare disease and neuroscience legacy.